The DuraSite® technology platform can be customized to deliver a wide variety of potential drug candidates. This powerful drug delivery technology offers a number of benefits for potential ocular drug candidates:
- Improved residence time in the tear film
- Improved absorption by the conjunctiva and cornea
- Dramatically reduced dosing schedule with potential once-a-day dosing
- Improved patient compliance
- Known safety profile
- Compatible with small molecules to high molecular weight proteins
For information about DuraSite technology licensing and partnership opportunities, contact Lyle Bowman at email@example.com.